Herbas VPB

Print
EN | LT
LT - Antikūnų ir SN-38 imunokonjugatų dozės, skirtos pagerintam veiksmingumui ir sumažintam toksiškumui
EN - DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

Legal status

Patent in force

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 47/68 (2017.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 2900277
(13) Kind of document T
(96) European patent application number 13861658.6
Date of filing the European patent application 2013-07-23
(97) Date of publication of the European application 2015-08-05
(45) Date of publication and mention of the grant of the patent 2022-02-16
(46) Date of publication of the claims translation 2022-04-11
PCT application
(86) Number PCT/US2013/051667
Date 2013-07-23
PCT application publication
(87) Number WO 2014/092804
Date 2014-06-19
Priority applications
(30) Number Date Country code
201261736684 P 2012-12-13 US
201361749548 P 2013-01-07 US
Inventors
(72)
GOVINDAN, Serengulam, V. , US
GOLDENBERG, David, M. , US
Grantee
(73) Immunomedics, Inc. , 300 American Road, Morris Plains, NJ 07950, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Antikūnų ir SN-38 imunokonjugatų dozės, skirtos pagerintam veiksmingumui ir sumažintam toksiškumui
  DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY
Last renewal fee
Payment date Validity (years) Amount
2025-06-18 13 289.00 EUR
Next renewal fee
2026-07-23
Last update date 2025-06-20